Researchers set out to map the structural connectomes, the comprehensive wiring diagrams of neural fiber tracts, of patients with severe, treatment-refractory obsessive-compulsive disorder, and to compare how the conventional deep brain stimulation targets are embedded within each individual’s connectome. Using diffusion magnetic resonance imaging, the team reconstructed the white matter pathways that connect distant brain regions and analyzed how the stimulation sites commonly used in clinical practice relate to the broader network organization of each patient’s brain. The central question was deceptively simple: when two patients receive stimulation at the same anatomical coordinate, are they actually stimulating the same circuit?

The answer, according to the findings, is a resounding no. The study revealed substantial patient-specific differences in the structural connectivity profile of the target regions most frequently used for obsessive-compulsive disorder, including the anterior limb of the internal capsule, the ventral capsule and striatum, the nucleus accumbens, and the bed nucleus of the stria terminalis. While these targets occupy broadly similar positions across patients, the specific fiber bundles passing through and around them, and the cortical and subcortical regions they link, vary considerably from one individual to the next. A coordinate that engages a particular fronto-striatal loop in one patient may recruit a partially different set of tracts and connection patterns in another.

This variability has profound implications for a field that has traditionally relied on group-averaged atlases to guide electrode placement. Standard neurosurgical practice often positions electrodes according to population-level templates, on the assumption that a given target occupies a comparable network position in most patients. The new connectomic analysis challenges that assumption directly. If the structural context of a target differs substantially across patients, then identical electrode placements may produce heterogeneous network effects, potentially explaining some of the striking inconsistency in clinical outcomes that has plagued obsessive-compulsive disorder stimulation studies for two decades.

Obsessive-compulsive disorder affects roughly one to two percent of the global population, characterized by intrusive, distressing obsessions and repetitive compulsions that can consume hours of each day. For the majority of patients, cognitive behavioral therapy and serotonin reuptake inhibitors provide meaningful relief. But a stubborn minority, estimated at around ten percent, derive little benefit from any conventional treatment. It is this treatment-resistant group for whom deep brain stimulation has been developed, and for whom the stakes of targeting precision are highest. The procedure is invasive, expensive and not without risk, so improving the odds of a successful outcome carries real clinical weight.

The technical approach behind the study relied on diffusion-weighted imaging, which tracks the directional movement of water molecules along axonal bundles to infer the trajectories of white matter tracts. From these data, the researchers constructed individualized connectomes, assigning each stimulation target a connectivity fingerprint describing which brain regions it is structurally linked to and with what strength. By quantifying the overlap and divergence of these fingerprints across patients, the team could measure, for the first time in a systematic way, how much of the apparent uniformity of standard targets is an artifact of averaging, and how much genuine inter-individual variation persists even in a relatively homogeneous patient population.

The results showed that while certain broad network features are conserved, including strong connections between the ventral capsule and striatal targets and prefrontal cortical regions implicated in compulsive behavior, the fine-grained connectivity differs in ways that could be clinically consequential. Some patients exhibited connectivity profiles that aligned closely with the tracts most often associated with favorable stimulation responses in the published literature, such as pathways linking the ventral striatum with medial frontal and limbic regions. Others showed markedly different configurations, with key tracts displaced or attenuated relative to the group average. In such patients, an electrode placed at the conventional coordinate might miss the optimal tract entirely, or engage competing pathways with unknown effects.

These findings dovetail with a growing body of evidence that the therapeutic effect of deep brain stimulation depends less on the precise anatomic address of an electrode and more on the specific white matter tracts it modulates. Parallel work in Parkinson’s disease, dystonia and treatment-resistant depression has converged on the idea that connectivity-informed targeting outperforms anatomy-informed targeting, and that tractographic models derived from patient-specific imaging can predict clinical outcomes better than distance from a group-defined sweet spot. The present study extends this connectomic framework to obsessive-compulsive disorder, providing quantitative evidence that the field’s conventional targets are not network-equivalent across patients.

The clinical implications are straightforward, even if their implementation will take time. The findings argue for incorporating individual diffusion imaging and connectomic analysis into the pre-surgical planning of deep brain stimulation for obsessive-compulsive disorder, rather than relying exclusively on atlas coordinates. They also suggest a framework for rational electrode adjustment, in which a patient’s poor response to stimulation could be reinterpreted as a wiring mismatch rather than a failure of the therapy itself, prompting tractography-guided revision. As imaging pipelines become faster and more automated, the marginal cost of patient-specific connectomic planning continues to fall, bringing such approaches closer to routine practice.

Important caveats remain. The study examined structural connectivity, the brain’s physical wiring, and did not directly measure function or clinical response, so the link between connectomic variability and therapeutic outcome, while strongly suggested, awaits direct validation in longitudinal cohorts. Diffusion imaging itself carries known limitations in resolving crossing fibers and distinguishing fiber populations. Nonetheless, the central message stands with unusual clarity: the brain targets that surgeons stimulate are not interchangeable points on a map, but individualized nodes in each patient’s unique neural network. For a disorder as heterogeneous and disabling as obsessive-compulsive disorder, that individuality may prove to be the key that finally unlocks consistent benefit from one of medicine’s most remarkable interventions.

Subject of Research: Patient-specific structural connectomic variability of deep brain stimulation targets in treatment-resistant obsessive-compulsive disorder

Article Title: Patient-specific structural connectomic differences of deep brain stimulation targets in treatment-resistant obsessive-compulsive disorder patients

Article References: Patient-specific structural connectomic differences of deep brain stimulation targets in treatment-resistant obsessive-compulsive disorder patients. (n.d.). https://doi.org/10.1038/s41398-026-04441-4

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04441-4

Keywords: deep brain stimulation, obsessive-compulsive disorder, connectomics, treatment-resistant OCD, diffusion MRI, white matter tracts, ventral capsule, nucleus accumbens, neurosurgery, translational psychiatry, brain networks, Patient-specific